Surmodics Inc. | Income Statement
Fiscal year is October-September. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
56,132.00
57,439.00
61,898.00
71,366.00
73,112.00
81,336
Cost of Goods Sold (COGS) incl. D&A
7,898.00
8,016.00
8,619.00
13,330.00
13,841.00
16,488
Gross Income
48,234.00
49,423.00
53,279.00
58,036.00
59,271.00
64,848
SG&A Expense
28,938.00
30,847.00
31,690.00
36,498.00
52,295.00
64,084
EBIT
19,296.00
18,576.00
21,589.00
21,538.00
6,976.00
764
Unusual Expense
634.00
1,184.00
4,000.00
4,679.00
127.00
9,563
Non Operating Income/Expense
1,430.00
842.00
396.00
26.00
460.00
416
Pretax Income
20,360.00
18,472.00
18,241.00
16,948.00
7,033.00
7,532
Income Tax
5,781.00
6,265.00
6,294.00
6,963.00
3,107.00
3,075
Consolidated Net Income
14,579.00
12,207.00
11,947.00
9,985.00
3,926.00
4,457
Net Income
14,579.00
12,207.00
11,947.00
9,985.00
3,926.00
4,457
Net Income After Extraordinaries
13,991.00
12,383.00
11,947.00
9,985.00
3,926.00
4,457
Net Income Available to Common
15,167.00
12,031.00
11,947.00
9,985.00
3,926.00
4,457
EPS (Basic)
1.03
0.87
0.90
0.76
0.29
0.34
Basic Shares Outstanding
14,464.00
13,632.00
13,029.00
12,998.00
13,153.00
13,157
EPS (Diluted)
1.03
0.87
0.90
0.76
0.29
0.34
Diluted Shares Outstanding
14,731.00
13,876.00
13,289.00
13,219.00
13,389.00
13,157
EBITDA
22,182.00
21,291.00
24,394.00
26,411.00
12,531.00
7,195
Non-Operating Interest Income
268.00
238.00
256.00
63.00
390.00
851
About Surmodics
View Profile
